Dong-qin Yang
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Micronucleus assay for monitoring the genotoxic effects of arsenic in human populations: A systematic review of the literature and meta-analysis.
Journal: Mutation research. Reviews in mutation research
Published: October 26, 2018
TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
Journal: Journal of cellular physiology
Published: September 19, 2017
Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome.
Journal: Clinical chemistry and laboratory medicine
Published: February 22, 2017
Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.
Journal: Clinical laboratory
Published: March 26, 2016
High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.
Journal: International journal of clinical and experimental pathology
Published: October 09, 2015
DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: August 21, 2015
Reduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemia.
Journal: Japanese journal of clinical oncology
Published: August 13, 2015
Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome.
Journal: Clinical chemistry and laboratory medicine
Published: June 09, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026